Cardiovascular complications are the major cause of mortality and morbidity in children with end-stage renal disease who are treated with chronic hemodialysis Arterial hypertension is a major cardiovascular risk factors in this population. The aim is that children who are on HD displays the prevalence of hypertension, to check arterial pressure before and after HD and displays the correlation with the left ventricle mass (LVM). Method: The study in 20 patients on chronic HD and 20 healthy control group children, blood pressure was measured by sphygmomanometer before and after HD. Also echocardiography were measured left ventricular mass before and after HD and track the correlation of these two parameters. Results: The prevalence of hypertension in children on HD is 62% for significant different compared to the control group (p <0.001) .. TA values of systolic and diastolic significantly lower after HD. (P <0.05). After HD TA values were significantly higher than the value of TA (p <0.05) in healthy children. The prevalence of LVH was 60% in children on HD and statistically be statistically highe then to the control group (p <0.001). The correlation between LVH and increased TA was linear but was not statistically significant in either group of patients. In conclusion: The fact that hypertension does not correlate significantly with left ventricular mass suggests that the increase in LVM except high blood pressure and affect other cardiovascular risk factors.
Vandevoorde R, Barletta G, Chand D, Dresner I, Lane J, Leiser J. Blood pressure control in pediatric hemodialysis: the Midwest Pediatric Nephrology Consortium Study. Pediatr Nephrol. 2007;547–53.
2.
Halbach S, Martz K, Mattoot T, Flynn. Predictors of Blood Pressure and Its Control in Pediatric Patients Receiving Dialysis. J Pediatr. 2012;(4):621–5.
3.
Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J. Masked hypertension associated with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol. 2010;137–44.
4.
Chavers B, Solid C, Daniels F, Chen S, Collins A, Frankenfield D. Hypertension in pediatric long-term hemodialysis patients in the United States. Clin J Am Soc Nephrol. 2009;1363–9.
5.
Mitsnefes M. Cardiovascular Disease in Children with Chronic Kidney Disease. J Am Soc Nephrol. 2012;578–85.
6.
Charra B, Calemard E, Laurent G. Importance of treatment time and blood pressure in achieving long-term survival on dialysis. Am J Nephrol. 1998;35–44.
7.
Krmar R, Berg U. Blood pressure control in hypertensive pediatric renal transplants: role of repeated ABPM following transplantation. Am J Hypertens. 2008;1093–9.
8.
Civilibal C, Sever L, Civilibal M, Caliskan S, Arisoy N. Blood volume monitoring to adjust dry weight in hypertensive pediatric hemodialysis patients. Pediatr Nephrol. 2009;581–7.
9.
Devereux R, Alonso D, Lutas E. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;450–8.
10.
Daniels S, Meyer R, Loggie J. Determinants of cardiac involvement in children and adolescents with essential hypertension. Circulation. 1990;1243–8.
11.
Daniels S, Meyer R, Liang Y, Bove K. Echocardiographically determined left ventricular mass index in normal children, adolescents, and young adults. I Am Coil Cardiol. 1988;703–8.
12.
Matteucci M, Wu E, Picca S. Left Ventricular Geometry in Children with Mild to Moderate Chronic Renal Insufficiency. Am Soc Nephrol. 2006;218–26.
13.
Sahn D, Demaria A, Kisslo J. Commiftee on M-Mode Standardizations of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: resuits of a survey of echocardiographic measurements. Circulation. 1978;107.
14.
Patel H, Goldstein S, Mahan J, Smith B, Fried C, Currier H. A standard, noninvasive monitoring of hematoHBIt algorithm improves blood pressure control in pediatric hemodialysis patients. Clin J Am Soc Nephrol. 2007;252–7.
15.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;555–76.
16.
Mitsnefes M. Cardiovascular Disease in Children with Chronic Kidney Disease. J Am Soc Nephrol. 2012;578–85.
17.
Workgroup K, K. DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;10–5.
18.
Cannella G, Paoletti E, Barocci S. Angiotensin-converting enzyme gene polymorphism and reversibility of uraemic left ventricular hypertrophy following longterm antihypertensive therapy. Kidney Int. 1998;618–26.
19.
Matteucci M, Wu E, Picca S. Left Ventricular Geometry in Children with Mild to Moderate Chronic Renal Insufficiency. Am Soc Nephrol. 2006;218–26.
20.
Flynn J. Hypertension in the young: epidemiology, sequelae, therapy. Nephrol Dialysis Transplant. 2009;370–5.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
